ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation
Worel N, Kalhs P, Keil F, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 2003;43:1153-61.
Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: A major ABO mismatch means problems
Worel N, Greinix HT, Schneider B, et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000;40:543-50.
Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia
Maschan AA, Skorobogatova EV, Balashov DN, et al. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 2002;30:405-7.
Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation
Bavaro P, Di Girolamo G, Olioso P, et al. Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation. Br J Haematol 1999;104:930-1.
Successful treatment of Epstein-Barr virus-associated lymphoproliferative disorder and pure red cell aplasia in a child with rituximab following a major ABO-incompatible unrelated cord blood transplantation
Abstract5547
Zhu K, Chen J, Chen S. Successful treatment of Epstein-Barr virus-associated lymphoproliferative disorder and pure red cell aplasia in a child with rituximab following a major ABO-incompatible unrelated cord blood transplantation. Blood 2003;102:Abstract5547.
Successful resolution of pure red cell aplasia following major ABO-imcompatible unrelated donor stem cell using rituximab: Transplantation
Abstract 5578
Al-Okk H, Diaz B, Stives S, Parumog N, Conway M, Nath R. Successful resolution of pure red cell aplasia following major ABO-imcompatible unrelated donor stem cell using rituximab: transplantation. Blood 2003;102:Abstract 5578.
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning
Badros A, Tricot G, Toor A, et al. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion 2002;42:205-9.